Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Nov 13, 2017 · 10-Q · 44 days after period end · 0001564590-17-023382
| Metric | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|
| Revenue | $6.17M | $2.82M | $6.56M |
| Net Income | $37.87M | -$71.74M | -$12.68M |
| EPS Diluted | $1.75 | -$3.55 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 13, 2017 · 44 d after period end
